Pardes Biosciences, Inc. (PRDS) Earning

NASDAQ Currency in USD Disclaimer

$2.18

north_east NA Past Year
Day's range
$2.13
Day's range
$2.18

Pardes Biosciences, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
08/04/2023 Q2 2023 -$0.34 -$0.18 0.16 $0
05/05/2023 Q1 2023 $0.39 -$0.24 -0.63 $0
03/14/2023 Q4 2022 $0.58 -$0.84 -1.42 $0
11/07/2022 Q3 2022 $0.49 -$0.37 -0.86 $0
08/15/2022 Q2 2022 $0.39 -$0.47 -0.86 $0
05/10/2022 Q1 2022 -$0.38 $0
03/29/2022 Q4 2021 -$0.22 -$0.25 -0.03 $0
11/12/2021 Q3 2021 -$0.20 $0
08/16/2021 Q2 2021 -$0.14 $0
05/17/2021 Q1 2021 -$0.08 $0
 

Pardes Biosciences, Inc. Earnings: FAQ's

When is Pardes Biosciences, Inc.'s earnings date?

Pardes Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 5th, 2023 based off last year's report dates.

Did Pardes Biosciences, Inc. beat their earnings estimates last quarter?

In the previous quarter, Pardes Biosciences, Inc. (:PRDS) reported $0.18 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.34 by $0.52.

How can I listen to Pardes Biosciences, Inc.'s earnings conference call?

The conference call for Pardes Biosciences, Inc.'s latest earnings report can be listened to online.

How can I read Pardes Biosciences, Inc.'s conference call transcript?

The conference call transcript for Pardes Biosciences, Inc.'s latest earnings report can be read online.

How much profit does Pardes Biosciences, Inc. generate each year?

Pardes Biosciences, Inc. (:PRDS) has a recorded net income of $0. Pardes Biosciences, Inc. has generated $-1.61 earnings per share over the last four quarters.

What is Pardes Biosciences, Inc.'s price-to-earnings ratio?

Pardes Biosciences, Inc. (:PRDS) has a price-to-earnings ratio of -1.36 and price/earnings-to-growth ratio is -0.01.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED